NORCROSS, Ga., June 1—SurgiLance™, a Singapore medical device company, announced today that it has listed its One-Step Safety Lancet with the U.S. Food and Drug Administration.
The innovative One-Step Safety Lancet is the first medical product to be commercialized by SurgiLance. The needle in the One-Step Safety Lancet is never exposed, either before or after use. This prevents any possibility of needlestick injury, which can cause diseases such as HIV and hepatitis.
Vice President of Business Development Patrick Yi said, "With the FDA listing, we can now commence discussions with companies interested in distributing the One-Step Safety Lancet in the United States."
SurgiLance was established in January 1999 to design, manufacture and sell safety medical devices. The SurgiLance™ One-Step Safety Lancet is the first product to be commercialized.
Ed. note: This release was published prior to MediPurpose™ changing its name from its prior company name—SurgiLance—in 2006.
© 2012 MediPurpose Private Limited | About Us | Contact Us | Terms of Use
Join MediPurpose on 
